Expert InterviewASND
Slingshot members are talking to an expert! The topic is:
Discussing the treatment landscape for hypoparathyroidism, including an overview of Ascendis' YORVIPATH (palopegteriparatide).
Executed on:Nov 10, 2025 5:00 PM EDT
Call Duration:30 minutes
Expert Profile
ExpertBlinded Expert
Institution: UCLA Health
- Clinical Endocrinologist and Program Director for the Endocrinology Fellowship Program at UCLA
- Manages 10 CAH and hypoparathyroidism patients
- Familiar with commercial and investigational agents in CAH
Interview Goal
This call will discuss the current treatment landscape for hypoparathyroidism and the potential of YORVIPATH (palopegteriparatide), recently approved by the FDA for the treatment of hypoparathyroidism in adults.